Top Stock Movers Today — August 12, 2026: Why RMCF, SMCX, NBIS, SION & SHAZ Surged
Rocky Mountain Chocolate Factory rocketed 126%, Nebius soared 34% on a revenue beat, and Sionna bounced 23% after yesterday's 92% collapse. Here's what drove the day's biggest stock gainers.
RMCF — Rocky Mountain Chocolate Factory, Inc. (+126.0%)
Rocky Mountain Chocolate Factory (RMCF) closed at $1.52, up an extraordinary 126% on volume of 45.57 million shares — roughly 20× its 20-day average of 2.3 million. That kind of volume surge in a stock with a market cap of just $6.8 million is the fingerprint of a momentum-driven micro-cap spike.
No specific catalyst was found in the headlines or SEC filings on file. The most recent filings are a routine August 7 management 8-K and a July 14 quarterly report, neither flagged as a market-moving event. With no confirmed news driver, this move appears technically and momentum-driven, likely amplified by the stock's very small size and extremely thin trading history.
RMCF's free float is 44.4% of shares outstanding — meaning roughly half the company's shares are locked up and not freely traded. A low float like this means even a modest surge in buy orders can push the price dramatically. Short interest is minimal (83,431 shares, 1.1 days to cover), so a classic short squeeze is unlikely to be the explanation here. The gap at the open was +158.7%, meaning the stock opened far above its prior close before settling somewhat — a hallmark of a micro-cap news or rumor spike that can reverse just as violently.
Technically, RSI hit 71 (overbought territory) and ADX of 41 confirms strong directional momentum, but the moving average stack is mixed, the stock sits 47.8% below its 52-week high, and StockSetups' conviction score is just 42/100 (grade D). The RS rating of 20 means this stock has dramatically underperformed the broader market over the prior year. With no confirmed catalyst and a sub-$7M market cap, mean-reversion risk is very high after a triple-digit single-day move.
SMCX — Defiance Daily Target 2X Long SMCI ETF (+36.7%)
SMCX is a leveraged ETF — not an individual stock — designed to deliver 2× the daily return of Super Micro Computer (SMCI). It closed up 36.7% at $12.56 on volume of 14.75 million shares, nearly 1.9× its 20-day average of 7.9 million.
Because SMCX is structured to double SMCI's single-day move, its 36.7% gain implies SMCI itself had a strong positive session. No independent catalyst for SMCX itself is on file, which is expected — this ETF's price is entirely a function of its underlying stock's daily performance, not its own news.
The ETF opened with a +19.4% gap, meaning it started the day well above its prior close, consistent with SMCI moving strongly in premarket trading. RSI sits at a moderate 64, and the ADX of 15 suggests directional momentum has not yet solidified. The stock sits 78% below its 52-week high, a reminder of how sharply leveraged ETFs decay in volatile, non-trending markets.
Leveraged ETFs like SMCX are designed for very short-term trading only. Because they reset their leverage daily, they can suffer significant "volatility decay" over time — meaning even if the underlying stock ends up flat over several weeks, the ETF can still lose value. Treat any position in SMCX as intraday or very short-term. StockSetups does not generate a conviction grade for this instrument.
NBIS — Nebius Group N.V. (+34.1%)
Nebius Group closed at $259.14, up 34.1% on 60.6 million shares — more than 2.3× its 20-day average of 26.1 million. This is by far the largest company on today's list, with a market cap of $48.8 billion, making the size of this move remarkable for a large-cap name.
WHY IT MOVED: Nebius reported its second-quarter 2026 financial results, and the numbers impressed. According to Yahoo Finance, "Nebius soars on second quarter revenue beat" as AI demand fueled growth. In a notable twist, the company posted a bigger-than-expected loss, yet the revenue beat was large enough to send shares sharply higher — a pattern seen when investors are focused on top-line growth trajectory rather than current profitability in high-growth AI infrastructure names. Nebius operates in AI cloud computing, a space generating intense investor interest in 2026.
Reddit picked up the story fast: NBIS jumped from 62 mentions to 467 mentions on r/all-stocks in 24 hours, landing at rank #2 site-wide. That kind of social-media velocity tends to pile onto institutional buying and can extend intraday moves — but also attract momentum traders who exit quickly.
The technical picture is the strongest of today's movers. StockSetups assigns NBIS a conviction score of 82/100 (grade A), a technical rank of 95, and an RS rating of 94 — meaning it has outperformed 94% of all stocks in the universe over the past year. The moving average stack is bullish, RSI is at a healthy 62 (not yet overbought), and the stock is only 9.6% below its 52-week high, suggesting real underlying trend strength heading into this catalyst. The trend-template score of 7/7 confirms the stock meets Minervini's demanding momentum criteria.
The short-squeeze score of 88/100 adds another layer of fuel. Short interest stands at 61 million shares with 3.5 days to cover (days to cover = short interest divided by average daily volume — the number of days it would take all short-sellers to buy back their positions). When a heavily shorted stock rockets on good news, short-sellers are forced to buy to cut losses, adding further buying pressure. Short volume on the day was 63%, a signal worth watching. One Congress member (Alan Armstrong, R) disclosed a buy of NBIS shares in March 2026. For more on how to find high-conviction setups like NBIS, see the Top Stock Movers Today — August 10, 2026 recap.
SION — Sionna Therapeutics, Inc. (+23.1%)
Sionna Therapeutics closed at $6.28, up 23.1% on 8.6 million shares — about 2.3× its 20-day average of 3.7 million. To understand today's bounce, you need to know what happened yesterday.
WHY IT MOVED: On August 11, SION cratered roughly 92% after its lead cystic fibrosis drug, SION-719, failed a Phase 2a clinical trial and the company halted its development. Per Yahoo Finance and MarketBeat, "Sionna Therapeutics stock falls 92% after SION-719 trial failure" and "Sionna Halts SION-719 After Phase 2a Miss, Eyes SION-451 Combination Path." Today's 23% gain is a dead-cat bounce — a partial recovery after a catastrophic drop — not a reversal of the underlying damage. The company noted it is now evaluating a combination approach with its other asset, SION-451, but the lead program is gone. A Vertex Pharmaceuticals headline referencing Sionna's failure as a competitive "moat" reinforces just how significant that trial miss was.
Today's bounce is likely driven by short-sellers locking in profits after the 92% collapse and by speculative traders betting on an oversold snap-back. The data supports this: squeeze score is 80/100, with a free float of only 18.5% — meaning very few shares trade freely, so any buying surge can move the price violently. Critically, days to cover is 11.5 — one of the highest readings on today's list — meaning short-sellers have 11.5 days of average volume worth of stock to buy back. Even a small reduction in short positions can have an outsized price impact on a thin-float biotech. Short volume on the day was just 22%, consistent with short-covering rather than new shorting.
Despite the bounce, the technical picture remains severely damaged. RSI has collapsed to 21 — deeply oversold — and the stock sits 87.7% below its 52-week high. The conviction score is 38/100 (grade D), and the RS rating is just 6. This is speculative territory. Biotech stocks that fail a key trial rarely recover their previous levels; the bounce from an extreme washout is often temporary. Manage risk accordingly.
SHAZ — SharonAI Holdings Inc. (+21.0%)
SharonAI Holdings closed at $68.48, up 21.0% on 6.2 million shares — roughly 2.5× its 20-day average of 2.5 million. The company operates in the Technology sector with a market cap of $554.9 million.
No confirmed news catalyst is on file for today's move. The most notable recent SEC filings include an S-1/A (an amended IPO registration statement) filed August 11 and a 10-Q/A (amended quarterly report) also filed August 11, alongside a Schedule 13G/A (a stake-change disclosure) from August 10. The amended S-1 may be drawing attention to the company as it moves through a registration process, but no specific headline explains the 21% gain. With no confirmed catalyst, this move reads as technically and momentum-driven, likely aided by the AI-themed name attracting attention in a market where AI infrastructure stocks (see NBIS above) had a strong session.
The StockSetups data gives SHAZ a conviction score of 74/100 (grade B) and a technical rank of 41. RSI is a neutral 56, and the stock opened with a +8.3% gap. It sits 26.1% below its 52-week high, leaving meaningful overhead supply. The squeeze score of 75/100 is notable: with 2.57 million shares short and only 1.3 days to cover, the actual short-covering pressure is modest — but a short-volume ratio of 61% suggests a significant portion of today's volume came from short-sellers, which can cut both ways depending on whether they were initiating new shorts into the rally or covering.
The largest disclosed stake is 19.9% of the company, a concentration worth monitoring. A single large holder can influence liquidity and price action significantly in a mid-cap name like this. Until a clear catalyst is confirmed, treat SHAZ's move with caution.
The bottom line
Today's biggest gainers — a micro-cap chocolate franchise, a leveraged ETF, an AI infrastructure giant, a battered biotech, and an AI-themed tech company — illustrate just how varied the drivers behind big single-day moves can be. NBIS had the clearest and most durable story: a genuine revenue beat in a high-growth sector with strong technicals and a squeeze setup behind it. The others require much more caution.
RMCF's 126% move with no confirmed catalyst is a reminder that the biggest percentage gainers are often the highest-risk trades. Micro-cap, low-float stocks can give back triple-digit gains in a single session. SION's bounce is speculative by definition — a 23% recovery after a 92% collapse is not a trend reversal. SMCX is a tool for sophisticated intraday traders, not a buy-and-hold position. And SHAZ, despite respectable conviction scores, lacks a confirmed news driver.
Chasing stocks after they have already made their biggest move is one of the most common — and costly — mistakes traders make. Patterns fail, squeezes unwind, and gaps fill. Always define your risk before entering any trade, size positions appropriately, and never risk more than you can afford to lose. Nothing in this recap is financial advice or a recommendation to buy or sell any security. Do your own research.
StockSetups scans the full ~12,300-stock US universe after every market close, detecting chart patterns, squeeze setups, and smart-money signals — so you can find the next mover before it moves. Check back tomorrow morning for the premarket recap.
Frequently asked questions
Why is RMCF stock up today?
RMCF surged 126% on August 12, 2026 on volume roughly 20x its 20-day average, but no specific news catalyst was confirmed. The move appears momentum- and technically-driven, amplified by the stock's extremely small market cap ($6.8M) and thin float. Moves like this in micro-caps carry very high reversal risk.
Why is NBIS (Nebius Group) stock up today?
Nebius Group surged 34.1% after reporting Q2 2026 results that beat revenue estimates, driven by strong AI infrastructure demand. Although the company posted a larger-than-expected loss, the top-line beat was enough to excite investors. A high short-squeeze score of 88/100 and 61 million shares short added further fuel as short-sellers were forced to cover.
Why is SION (Sionna Therapeutics) up today after crashing yesterday?
SION bounced 23.1% on August 12 after collapsing roughly 92% on August 11 when its lead cystic fibrosis drug SION-719 failed a Phase 2a trial. Today's gain is likely a short-covering bounce and speculative snap-back, not a recovery of the company's fundamental value. The stock remains 87.7% below its 52-week high.
What is a low-float short squeeze?
A low-float stock has relatively few shares available for public trading. When a large percentage of those shares are sold short (borrowed and sold in a bet the price will fall), any sudden price spike can force short-sellers to buy shares to cut their losses — adding more buying pressure and accelerating the rally. This self-reinforcing loop is called a short squeeze, and it can cause extreme, fast moves in either direction.
What does 'days to cover' mean?
'Days to cover' (also called the short ratio) is the number of days it would take all short-sellers in a stock to buy back their positions, based on the stock's average daily trading volume. A high days-to-cover reading (like SION's 11.5) means short-sellers would need many days of average volume to exit — making a short squeeze more potent if the stock rises unexpectedly.
Produced with AI assistance and published under the StockSetups editorial guidelines.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →